USPTO serial 79214833
AUREGEN BIOTHERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 5521659Status 709
- Filing date
- Status date
- Registration date
- Jul 24, 2018
- Examiner
- MAIHOS, JESSIE ANDREA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AUREGEN BIOTHERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gary D. Krugman
Gary D. Krugman Sughrue Mion, PLLC2000 Pennsylvania Avenue NW, Suite 900Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological implants, namely, a vital processed human or animal connective tissue; biological tissue for implantation; cells for medical use; human tissue for allografts; living cells for medical use; implants comprised of living tissue for guided tissue regeneration; implants comprising living tissue; implantable materials comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants composed of living tissue; vascular grafts being living tissue; biological molecules to assist with the development of tissue, namely, peptides, polypeptides, nucleosides, amino acids; natural biomaterials for bone and tissue augmentation for medical use; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; surgical implants comprising living tissues; biological tissue cultures for medical purposes, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment | SECTION 71 - CANCELLED | — |
| 009 | Laboratory apparatus for the manufacture of living tissue and three-dimensional organs, namely, incubators and cell culture apparatus for laboratory use for the manufacture of living tissue and three dimensional organs; laboratory apparatus specially adapted for scientific research performed in laboratories for the manufacture of living tissue and three dimensional organs; bioreactors for cell culture; print heads for ink-jet printers; laboratory equipment for scientific use and research, namely, systems comprising a liquid distributor, an imaging facility being medical imaging equipment, related control software, and related analysis software, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment | SECTION 71 - CANCELLED | — |
| 040 | 3D printing services; 3D printing services, namely, customized creation of three-dimensional parts using rapid prototyping equipment; 3D biological printing services; biological 3D printing services | SECTION 71 - CANCELLED | — |
| 042 | Technical research in the field of biomaterials, 3D bioprinting and tissue engineering; three-dimensional biological printing research; tissue engineering research; scientific and medical research and development in the field of bioprinting; research and development of 3D processes and technology; scientific services relating to the isolation and cultivation of human tissues and cells, excluding services used for a diagnosis; scientific and medical research and development in the field of the manufacture of tissue; development and culture of artificial tissue and cells in the nature of tissue engineering; tissue engineering services; industrial analysis and research services in the field of tissue engineering, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment | SECTION 71 - CANCELLED | — |
| 044 | Medical services in the field of cellular immunotherapy and transplant, excluding services used for a diagnosis; human cell and tissue bank services; medical services regarding the collection and preservation of cells for medical use, all of the aforementioned for in vivo use in the fields of therapeutic and aesthetic treatment | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Auregen BioTherapeutics SA
- Other trademarks owned by Auregen BioTherapeutics SA
- Other trademarks owned by Auregen BioTherapeutics SA
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AUREGEN BIOTHERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 30, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 30, 2026 | INPC | INVALIDATION PROCESSED | — |
| Oct 7, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 7, 2025 | C71T | CANCELLED SECTION 71 | — |
| Jul 24, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 14, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 23, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 6, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 6, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 24, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 24, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 19, 2018 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jun 15, 2018 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| May 8, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 8, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 18, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2018 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 16, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 14, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 22, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 7, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 16, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 16, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 13, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 12, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 5, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 31, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 25, 2017 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 24, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |